PharmaEssentia Corporation PharmaEssentia Corporation

PharmaEssentia Corporation

6446

Hisse Senetlerindeki Sıralama #1450
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Hisse Fiyatı
$36.43
Piyasa Değeri
$15.07B
Değişim (1 gün)
0.43%
Değişim (1 yıl)
141.85%
Ülke
TW
Ticaret PharmaEssentia Corporation (6446)

Kategori

Healthcare
PharmaEssentia Corporation (6446) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $37.52 - 2026-10-01

Gün sonu en düşük fiyat: $4.95 - 2014-03-01
PharmaEssentia Corporation için hisse fiyatı geçmişi: 2014 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 78.21%
2025 -1.54%
2024 65.30%
2023 -34.57%
2022 52.79%
2021 220.53%
2020 2.39%
2019 -41.63%
2018 21.23%
2017 -8.25%
2016 -3.31%
2015 21.68%
2014 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$171.67 -
DE
$161.15 20.52%
DE
$40.45 43.11%
JP
$212.49 24.09%
CH
$7.02 -23.31%
CN